[ Price : $8.95]
CNBC reports that HHS plans to appoint two new FDA deputy commissioners in hopes of exerting more influence over the agency.[ Price : $8.95]
FDA says the Boston Scientific recall of its ENROUTE Transcarotid Neuroprotection System is Class 1.[ Price : $8.95]
Participants in a 4/23 FDA meeting on increasing access to nonprescription drugs see a need to improve the electronic health recor...[ Price : $8.95]
An oncology physician association says its members are reporting a shortage of the chemotherapy agent ifosfamide for which no dire...[ Price : $8.95]
CDRH issues an early alert to notify the public about an Abiomed action recommending that all Automated Impella Controllers be rem...[ Price : $8.95]
Two physicians affiliated with Stanford Universitys medical school urge FDA to approve carbetocin for preventing postpartum hemorr...[ Price : $8.95]
Celcuity files a supplemental NDA for Revtorpyk (gedatolisib) for treating certain patients with hormone receptor positive, human ...[ Price : $8.95]
FDA approves Revolution Medicines Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer.